Who
Kevin Feeley
Chief Financial Officer
Company insider
Files Form 4 as: Chief Financial Officer, GeneDx Holdings.
In numbers
- Trades disclosed
- 325
- Buys
- 0
- Sells
- 68
- Bought
- $0
- Sold
- $18.3M
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 1 Sep 2022
- Last trade
- 16 Sep 2026
- Last filed
- 18 Sep 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 16 Sep 2026filed 18 Sep 2026 | WGS GeneDx HoldingsProviders & Facilities | SEC FORM 4 Code M | —7,197 at $0.00 | filing |
| 16 Sep 2026filed 18 Sep 2026 | WGS GeneDx HoldingsProviders & Facilities | SEC FORM 4 Sold | $55K586 at $94.26 | filing |
| 16 Sep 2026filed 18 Sep 2026 | WGS GeneDx HoldingsProviders & Facilities | SEC FORM 4 Sold | $4,96152 at $95.41 | filing |
| 16 Sep 2026filed 18 Sep 2026 | WGS GeneDx Holdingsoption or derivative · Providers & Facilities | SEC FORM 4 Code M | —7,197 at $0.00 | filing |
| 16 Sep 2026filed 18 Sep 2026 | WGS GeneDx HoldingsProviders & Facilities | SEC FORM 4 Sold | $52K541 at $96.90 | filing |
| 16 Sep 2026filed 18 Sep 2026 | WGS GeneDx HoldingsProviders & Facilities | SEC FORM 4 Sold | $144K1,470 at $98.27 | filing |
| 16 Sep 2026filed 18 Sep 2026 | WGS GeneDx HoldingsProviders & Facilities | SEC FORM 4 Sold | $107K1,079 at $99.00 | filing |
| 16 Sep 2026filed 18 Sep 2026 | WGS GeneDx Holdingsoption or derivative · Providers & Facilities | SEC FORM 4 Code M | —7,197 at $0.00 | filing |
| 16 Sep 2026filed 18 Sep 2026 | WGS GeneDx HoldingsProviders & Facilities | SEC FORM 4 Code M | —7,197 at $0.00 | filing |
| 16 Sep 2026filed 18 Sep 2026 | WGS GeneDx HoldingsProviders & Facilities | SEC FORM 4 Sold | $55K586 at $94.26 | filing |
| 16 Sep 2026filed 18 Sep 2026 | WGS GeneDx HoldingsProviders & Facilities | SEC FORM 4 Sold | $4,96152 at $95.41 | filing |
| 16 Sep 2026filed 18 Sep 2026 | WGS GeneDx HoldingsProviders & Facilities | SEC FORM 4 Sold | $52K541 at $96.90 | filing |
| 16 Sep 2026filed 18 Sep 2026 | WGS GeneDx HoldingsProviders & Facilities | SEC FORM 4 Sold | $144K1,470 at $98.27 | filing |
| 16 Sep 2026filed 18 Sep 2026 | WGS GeneDx HoldingsProviders & Facilities | SEC FORM 4 Sold | $107K1,079 at $99.00 | filing |
| 9 Sep 2026filed 11 Sep 2026 | WGS GeneDx HoldingsProviders & Facilities | SEC FORM 4 Code M | —2,462 at $0.00 | filing |
| 9 Sep 2026filed 11 Sep 2026 | WGS GeneDx HoldingsProviders & Facilities | SEC FORM 4 Sold | $108K1,285 at $84.22 | filing |
| 9 Sep 2026filed 11 Sep 2026 | WGS GeneDx Holdingsoption or derivative · Providers & Facilities | SEC FORM 4 Code M | —2,462 at $0.00 | filing |
| 9 Sep 2026filed 11 Sep 2026 | WGS GeneDx Holdingsoption or derivative · Providers & Facilities | SEC FORM 4 Code M | —2,462 at $0.00 | filing |
| 9 Sep 2026filed 11 Sep 2026 | WGS GeneDx HoldingsProviders & Facilities | SEC FORM 4 Code M | —2,462 at $0.00 | filing |
| 9 Sep 2026filed 11 Sep 2026 | WGS GeneDx HoldingsProviders & Facilities | SEC FORM 4 Sold | $108K1,285 at $84.22 | filing |
News
Kevin Feeley Sells 1,285 Shares of GeneDx (NASDAQ:WGS) Stockthemarketsdaily.com · 13 Sep 2026
1 headline in the last 90 days name Kevin Feeley; 0 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.